Latest news with #McCoyGlobal
Yahoo
30-05-2025
- Business
- Yahoo
TSX Gems: McCoy Global And 2 Other Promising Penny Stocks
With recent fluctuations in bond yields and potential changes to U.S.-Canada tax treaties, Canadian investors are navigating a complex landscape. Amid these broader market dynamics, penny stocks remain an intriguing area for those interested in smaller or newer companies. Although the term "penny stocks" might seem outdated, it still represents opportunities for growth by focusing on firms with solid financial foundations and potential for long-term success. Name Share Price Market Cap Financial Health Rating Westbridge Renewable Energy (TSXV:WEB) CA$0.76 CA$73.84M ★★★★★★ NTG Clarity Networks (TSXV:NCI) CA$2.67 CA$107.9M ★★★★★★ Intermap Technologies (TSX:IMP) CA$2.26 CA$132.09M ★★★★★☆ Thor Explorations (TSXV:THX) CA$0.70 CA$465.71M ★★★★★★ Orezone Gold (TSX:ORE) CA$1.23 CA$669.5M ★★★★★☆ McChip Resources (TSXV:MCS) CA$0.84 CA$4.57M ★★★★★★ Hemisphere Energy (TSXV:HME) CA$1.80 CA$173.01M ★★★★★★ PetroTal (TSX:TAL) CA$0.60 CA$539.84M ★★★★★☆ Pulse Seismic (TSX:PSD) CA$2.63 CA$131.96M ★★★★★★ Findev (TSXV:FDI) CA$0.45 CA$12.75M ★★★★★★ Click here to see the full list of 900 stocks from our TSX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: McCoy Global Inc. offers equipment and technologies for tubular running operations to improve wellbore integrity and data collection in the energy industry across various global regions, with a market cap of CA$97.66 million. Operations: The company generates revenue from its Energy Products & Services (EP&S) segment, which amounted to CA$80.32 million. Market Cap: CA$97.66M McCoy Global Inc. has demonstrated solid financial performance, with a recent earnings growth of 26.7%, surpassing the broader Energy Services industry. The company remains debt-free and has maintained stable weekly volatility at 13%. Recent announcements highlight successful commercialization of its smarTR™ technology, securing $11 million in contracts, which could enhance future revenue streams. Despite trading significantly below its estimated fair value, McCoy's return on equity is relatively low at 13.4%. The board and management teams are experienced, contributing to the company's strategic direction and operational stability amidst an unstable dividend track record. Take a closer look at McCoy Global's potential here in our financial health report. Explore McCoy Global's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Regulus Resources Inc. is a mineral exploration company active in Canada and Peru, with a market cap of CA$261.78 million. Operations: Regulus Resources Inc. has not reported any revenue segments. Market Cap: CA$261.78M Regulus Resources Inc., with a market cap of CA$261.78 million, is currently pre-revenue, focusing on mineral exploration in Canada and Peru. The company has a cash runway of over two years if free cash flow continues to grow as historically observed. Recent updates highlight progress in the Nuton Phase Two metallurgical test program at the AntaKori project, achieving promising copper extraction rates using bio-leaching technology. Additionally, Regulus is advancing an integrated resource estimate for the Integrated Sulphide Project with Coimolache S.A., aiming to optimize geological understanding and resource potential. The company remains debt-free with stable short-term financials. Jump into the full analysis health report here for a deeper understanding of Regulus Resources. Explore historical data to track Regulus Resources' performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Theralase Technologies Inc. is a clinical stage pharmaceutical company focused on the research, development, and commercialization of light-activated photodynamic compounds for treating cancers, bacteria, and viruses globally, with a market cap of CA$47.27 million. Operations: The company's revenue is primarily derived from its Device segment, which generated CA$1.03 million. Market Cap: CA$47.27M Theralase Technologies Inc., with a market cap of CA$47.27 million, is a clinical-stage pharmaceutical company currently pre-revenue, focusing on light-activated compounds for treating various diseases. The company's short-term assets of CA$1.6 million exceed its liabilities, providing some financial stability despite recent auditor concerns about its ability to continue as a going concern. Theralase has made significant strides in its clinical trials for bladder cancer treatment and is actively seeking commercialization partners as it nears completion of Study II. Recent preclinical results also show promising efficacy in cancer and viral treatments, potentially enhancing future revenue streams. Dive into the specifics of Theralase Technologies here with our thorough balance sheet health report. Gain insights into Theralase Technologies' future direction by reviewing our growth report. Take a closer look at our TSX Penny Stocks list of 900 companies by clicking here. Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:MCB TSXV:REG and TSXV:TLT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
07-03-2025
- Business
- Yahoo
Does McCoy Global (TSE:MCB) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But as Peter Lynch said in One Up On Wall Street, 'Long shots almost never pay off.' Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in McCoy Global (TSE:MCB). Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide McCoy Global with the means to add long-term value to shareholders. See our latest analysis for McCoy Global Generally, companies experiencing growth in earnings per share (EPS) should see similar trends in share price. That means EPS growth is considered a real positive by most successful long-term investors. Shareholders will be happy to know that McCoy Global's EPS has grown 31% each year, compound, over three years. If growth like this continues on into the future, then shareholders will have plenty to smile about. Top-line growth is a great indicator that growth is sustainable, and combined with a high earnings before interest and taxation (EBIT) margin, it's a great way for a company to maintain a competitive advantage in the market. While we note McCoy Global achieved similar EBIT margins to last year, revenue grew by a solid 11% to CA$78m. That's progress. You can take a look at the company's revenue and earnings growth trend, in the chart below. For finer detail, click on the image. Since McCoy Global is no giant, with a market capitalisation of CA$66m, you should definitely check its cash and debt before getting too excited about its prospects. It's said that there's no smoke without fire. For investors, insider buying is often the smoke that indicates which stocks could set the market alight. That's because insider buying often indicates that those closest to the company have confidence that the share price will perform well. Of course, we can never be sure what insiders are thinking, we can only judge their actions. We haven't seen any insiders selling McCoy Global shares, in the last year. So it's definitely nice that Independent Director Michael Buker bought CA$44k worth of shares at an average price of around CA$2.02. It seems that at least one insider is prepared to show the market there is potential within McCoy Global. If you believe that share price follows earnings per share you should definitely be delving further into McCoy Global's strong EPS growth. Not only is that growth rate rather juicy, but the insider buying adds fuel to the fire. To put it succinctly; McCoy Global is a strong candidate for your watchlist. It is worth noting though that we have found 2 warning signs for McCoy Global that you need to take into consideration. The good news is that McCoy Global is not the only stock with insider buying. Here's a list of small cap, undervalued companies in CA with insider buying in the last three months! Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
